Redmile Group LLC 13D and 13G filings for Amicus Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 8:00 pm Sale |
2024-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 14,184,495 4.600% |
-1,191,702 (-7.75%) |
Filing |
| 2024-11-14 9:00 pm Sale |
2024-09-30 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 15,376,197 5.100% |
-6,581,729 (-29.97%) |
Filing |
| 2024-02-14 4:26 pm Sale |
2023-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 21,957,926 7.300% |
-6,641,568 (-23.22%) |
Filing |
| 2023-02-14 4:16 pm Purchase |
2022-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 28,599,494 9.900% |
194,452 (+0.68%) |
Filing |
| 2022-02-14 5:07 pm Purchase |
2021-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 28,405,042 9.990% |
6,279,553 (+28.38%) |
Filing |
| 2021-02-16 4:06 pm Sale |
2020-12-31 | 13G | Amicus Therapeutics, Inc. FOLD |
Redmile Group LLC | 22,125,489 8.500% |
-3,357,280 (-13.17%) |
Filing |